![]() | |
![]() | |
Names | |
---|---|
Preferred IUPAC name 5-Amino-6-(7-amino-6-methoxy-5,8-dioxo-5,8-dihydroquinolin-2-yl)-4-(2-hydroxy-3,4-dimethoxyphenyl)-3-methylpyridine-2-carboxylic acid | |
Other names Rufocromomycin, nigrin, bruneomycin [1] | |
Identifiers | |
3D model (JSmol) | |
599390 | |
ChEBI | |
ChEMBL | |
ChemSpider | |
ECHA InfoCard | 100.021.366 |
EC Number |
|
1240693 | |
KEGG | |
PubChem CID | |
UNII | |
CompTox Dashboard (EPA) | |
| |
| |
Properties | |
C25H22N4O8 | |
Molar mass | 506.471 g·mol−1 |
Hazards | |
GHS labelling: | |
![]() | |
Danger | |
H300 | |
P264, P270, P301+P316, P321, P330, P405, P501 | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). |
Streptonigrin is an aminoquinone antitumor and antibacterial antibiotic produced by Streptomyces flocculus . [1] It is an inhibitor of nitric oxide-dependent activation of soluble guanylyl cyclase. [2]
The first total synthesis of streptonigrin was published in 1980, [3] a different total synthesis with significantly higher yield was reported in 2011. [4]